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Abstract
Objectives: The occurrence of postoperative pancreatic fistula (POPF) is the main cause of severe
complications, including death, after pancreatic surgery. This study was conduced to evaluate current
practice in the management of POPF after Whipple surgery and distal pancreatectomy (DP).
Methods: An online survey endorsed by the European–African Hepato-Pancreato-Biliary Association
(E-AHPBA) was conducted among surgical departments active in pancreatic surgery. A total of 108
centres were contacted by e-mail. The survey focused on the use and timing of drainage, nutrition
strategies, provision of somatostatin and antibiotic therapies, imaging strategy and indications for
reoperation when POPF is diagnosed after pancreatic surgery.
Results: A total of 55 centres (51%) completed the survey. Overall, responses showed poor agreement
among centres (Fleiss' kappa: <0.40) on 89% of items after Whipple surgery and 78% of items after DP.
There was very poor or no agreement (Fleiss' kappa: <0.1) on postoperative strategies for the manage-
ment of nutrition and use of somatostatin after both procedures. In the event of POPF, 42% of centres
used total oral nutrition and 22% used somatostatin after Whipple surgery, and 71% used total oral
nutrition and 31% used somatostatin after DP. There were significant disagreements between units
conducting, respectively, more and fewer than 50 Whipple procedures per year on drain removal after DP,
and imaging strategy and patient discharge after Whipple surgery and DP.
Conclusions: This survey discloses important disagreements worldwide regarding the management of
POPF after both Whipple surgery and DP. The standardized management of POPF would better facilitate
the comparison of outcomes in future trials.
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Introduction
Postoperative pancreatic fistula (POPF) is one of the most com-
monly encountered complications after pancreatic surgery.1 Its
incidence varies considerably according to the type of pancreatic
resection (Whipple, distal or central resection, or enucleation)
and the definition used. Incidences of POPF range from 0% to
24%, and are reported to hover around 13% afterWhipple surgery
and to occur in 30–40% of patients after distal pancreatectomy
(DP).2–5 The occurrence of POPF may lead to intra-abdominal
abscess, haemorrhage and sepsis, any of which may translate to a
significant increase in hospital stay and costs.6 In this setting, three
steps are of primary concern; these refer to the prevention, diag-
nosis and management of POPF. Although the diagnosis and
prevention of POPF have been extensively discussed in the
literature,7–10 data on the management of POPF once it has been
diagnosed are scarce and lack standardization.11–13
With reference to the management of POPF, the optimal drain-
age of the remnant exocrine pancreas, nutritional support, use of
somatostatin and antibiotics remain subject to controversy.11,14,15
In addition, imaging strategy and indications for reoperation are
paramount to the control of fistula-related complications. The
principal aim in the management of POPF is to reduce the risk for
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severe fistula-related complications and to improve the nutri-
tional condition of POPF patients, who are in a catabolic state.
Therefore, the purpose of this study was to evaluate current
practice in the management of POPF after Whipple surgery and
DP in hepatopancreatobiliary (HPB) centres worldwide.
Materials and methods
This survey was endorsed by the European–African Hepato-
Pancreato-Biliary Association (E-AHPBA). A total of 108 HPB
department heads around the world (North America, South
America, Asia, Australia, New Zealand, Europe and Africa) were
invited to participate in the survey by e-mail. Many HPB surgeons
were personally contacted during the 2011 bi-annual E-AHPBA
meeting (Cape Town, South Africa, 12–16 April 2011). The invi-
tation letter included a direct link to the online survey available
on the E-AHPBA website (http://www.e-ahpba.org/?q=pancreas-
survey). Up to four reminder e-mails were sent. Data analysis and
reporting were performed in an anonymized manner.
This survey covered six main aspects of current practice in the
management of POPF after Whipple surgery and DP: (i) use and
duration of drainage; (ii) strategies for the provision of nutrition;
(iii) use of somatostatin analogues; (iv) use of antibiotics; (v)
imaging strategy, and (vi) indications for reoperation. It included
15 questions for each type of procedure; only one answer could be
given to each item. The survey was valid only if all of the questions
had been addressed. Comments or suggestions could be added at
the end of the survey.
Statistical methods
Continuous variables were compared using the Mann–Whitney
U-test. Differences among proportions derived from categorical
data were compared using Fisher’s exact test. Agreement among
the participating centres was assessed according to Fleiss’ kappa
statistic. Fleiss’ kappa assesses the reliability of agreement among
a number of raters (three or more) when assigning categorical
ratings to a number of items.16 Cohen’s kappa was used to assess
agreement between practices after Whipple surgery and DP,
respectively, on items 7a to 15b (questions are available at http://
www.e-ahpba.org/?q=pancreas-survey). The measure calculates
the degree of agreement in classification over that which would be
expected by chance and is scored as a number between 0 and 1.
Kappa values of 0.41–1.0 indicate ‘good’ agreement, 0–0.40 ‘poor’
agreement, and statistics of <0 indicate no agreement among par-
ticipating centres. The continuous variable ‘Number of Whipple
procedures performed per year’ was dichotomized by using the
arbitrary 50th quartile (i.e. the median) as a cut-off point to
discriminate a participating centre as a high- or low-throughput
unit for pancreatic surgery.17 All P-values were two-sided and were
considered to indicate statistical significance at values of 0.05.
Statistical analysis was performed using IBM spss Statistics
Version 20 for Mac (IBM SPSS, Inc., Chicago, IL, USA).
Results
Fifty-five HPB centres (51%) completed the online survey. The
majority of the institutions were located in Europe (n = 40, 73%).
The other participating centres were situated in the Americas
(n = 8), Asia (n = 5), Australia (n = 1) and Africa (n = 1). Overall,
a median of 50 Whipple procedures [interquartile range (IQR):
25–65] and 20 DPs (IQR: 12–30) were performed each year in the
various participating institutions. A total of 69% of respondents
(n = 38) reported that they performed pancreaticojejunostomy
duringWhipple surgery. A total of 82% (n = 45) reported suturing
the pancreatic stump in DP. Use of postoperative prophylactic
drainage was reported by 93% of centres (n = 51) after Whipple
surgery and 91% (n = 50) after DP.
Level of agreement among participating centres
Table 1 lists all items on the questionnaire related to the manage-
ment of POPF after Whipple surgery and DP and shows the level
of agreement among centres. Agreement among centres on the
management of POPF was poor or absent on 89% of items per-
taining to Whipple surgery and 78% of items pertaining to DP. In
particular, the level of agreement among centres was very poor
(k < 0.1) on the management of nutrition after Whipple surgery
and on the use of somatostatin after both Whipple surgery and
DP. Total oral nutrition was used by 42% of centres after Whipple
surgery and 71% after DP. The decision to start oral feeding was
not based on the status of POPF in 46% of centres after Whipple
surgery and 49% after DP. Use of somatostatin was reported by
91% of centres after Whipple surgery and 80% after DP. The most
common duration of use of somatostatin was 7 days after both
Whipple surgery (44%) and DP (35%).
More than 90% of centres reported the use of antibiotics after
bothWhipple surgery and DP.More than 80% of centres reported
that the prophylactic drain was removed in the event of low
output of amylase-rich fluid with (16%) or without (73%) previ-
ous imaging after both Whipple surgery and DP. Finally, patients
were reportedly discharged once the fistula was draining well
(drain in situ) and oral nutrition was well tolerated by 76% of
centres after Whipple surgery and 84% after DP.
Level of agreement on management after Whipple
surgery and DP
For 93% of items on the questionnaire, agreement among centres
on themanagement of POPFwas good whenWhipple surgery was
compared to DPs (Table 1). The lowest level of agreement referred
to the type of nutrition used: 42% of centres reported the use of
total oral nutrition after Whipple surgery, whereas 71% reported
its use after DP; 29% of centres reported the use of no oral nutri-
tion and total parenteral nutrition (TPN) after Whipple surgery,
compared with 20% after DP, and 29% of centres reported the use
of no oral nutrition and the provision of total enteral nutrition
using a feeding tube after Whipple surgery, compared with 9%
after DP.
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Level of agreement according to number of Whipple
procedures performed per year
A total of 28 centres (51%) reported that they performed more
than 50Whipple procedures per year. In centres performing more
or fewer than 50 Whipple procedures per year (high- and low-
volume centres, respectively), the median numbers of procedures
performed were 65 (IQR: 58–80) and 25 (IQR: 20–35), respec-
tively. Table 2 lists responses to items on the survey according to
Table 1 Items on the questionnaire related to the management of postoperative pancreatic fistula after pancreatic surgery and answers from
participating centres (n = 55)
Items Answer options Whipple
procedure
Fleiss'
k-valuea
Distal
pancreatectomy
Fleiss'
k-valuea
Cohen's
k-valueb
n % n %
Criteria for
drain
removal
No specific criteria 6 11% 0.339 7 13% 0.337 0.832
Low output of amylase-rich fluid 40 73% 40 73%
Low output of amylase-rich fluid and no
residual collection on imaging
9 16% 8 15%
Nutrition after
fistula
diagnosis
No oral nutrition and total enteral nutrition
using a feeding tube
16 29% -0.002 5 9% 0.318 0.471
No oral nutrition and TPN 16 29% 11 20%
Total oral nutrition 23 42% 39 71%
Oral feeding
after TPN
This decision is not based on the status
of the PF
25 46% 0.080 27 49% 0.161 0.843
When the PF is healed 7 13% 3 6%
When the PF output decreases 23 42% 25 46%
Somatostatin
use
Intraoperatively in all cases 11 20% 0.038 10 18% 0.019 0.675
Intraoperatively in cases of soft pancreas
only
20 36% 13 24%
Never 5 9% 11 20%
Once a PF appears 12 22% 17 31%
Preoperatively in all cases 7 13% 4 7%
Somatostatin
duration
7 days 24 44% 0.079 19 35% 0.026 0.759
<7 days 10 18% 9 16%
>7 days 6 11% 5 9%
Never use it 5 9% 10 18%
Until the PF heals 10 18% 12 22%
Antibiotics In cases of suspected infection 29 53% 0.241 29 53% 0.208 0.936
Never prescribe antibiotics 3 6% 4 7%
Systematically after surgery (prophylactic) 22 40% 20 36%
Systematically when PF appears 1 2% 2 4%
Imaging
strategy
Before removing the prophylactic drains 3 6% 0.282 3 6% 0.305 0.961
In all cases, once a PF has been
diagnosed
15 27% 14 26%
Only when an infected intra-abdominal
collection is suspected
37 67% 38 69%
Criteria for
re-laparotomy
High PF output 0 0% 0.893 0 0% 0.945 0.658
Symptomatic collection which is
undrainable by interventional radiology
53 96% 54 98%
For both cases 2 4% 1 2%
Patient
discharge
Once the PF is draining well (drain in situ)
and oral nutrition is well tolerated
42 76% 0.265 46 84% 0.442 0.775
Once the PF has completely healed 13 24% 9 16%
aAgreement among 55 responding centres on each question after Whipple surgery or distal pancreatectomy.
bAgreement in the contexts of Whipple surgery and distal pancreatectomy on each question.
PF, pancreatic fistula; DP, distal pancreatectomy; TPN, total parenteral nutrition.
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Table 2 Items on the questionnaire and answers from centres performing more or fewer than 50 Whipple procedures per year
Items Answer options Centres performing >50
Whipple procedures
per year (n = 28)
Centres performing <50
Whipple procedures
per year (n = 27)
P-value
n % n %
Type of anastomosis during
Whipple procedure
Pancreaticojejunostomy 22 79% 16 59% 0.085
Pancreaticogastrostomy 4 14% 3 11%
Both 2 7% 8 30%
Pancreatic stump treatment
during DP
Simple closure of the main pancreatic duct 9 32% 17 63% 0.031
Suture of the pancreatic stump 24 86% 21 78% 0.503
Pancreaticojejunostomy 0 0% 2 7% 0.236
Stapling 14 50% 10 37% 0.418
Omental plug 3 11% 2 7% 1.000
Use of prophylactic drains
after Whipple procedure
No 2 7% 2 7% 0.452
Yes, with an active vacuum suction 8 29% 12 44%
Yes, with free drainage 18 64% 13 48%
Use of prophylactic drains
after DP
No 3 11% 2 7% 0.622
Yes, with an active vacuum suction 8 29% 11 41%
Yes, with free drainage 17 61% 14 52%
Criteria for removing drain
after Whipple procedure
No specific criteria 3 11% 3 11% 0.148
When output of amylase-rich fluid is low 23 82% 17 63%
When output of amylase-rich fluid is low and imaging
shows no residual collection
2 7% 7 26%
Criteria for removing drain
after DP
No specific criteria 3 11% 4 15% 0.044
When output of amylase-rich fluid is low 24 86% 16 59%
When output of amylase-rich fluid is low and imaging
shows no residual collection
1 4% 7 26%
Nutrition after fistula
diagnosis (after Whipple
procedure)
No oral nutrition and total enteral nutrition using a
feeding tube
7 25% 9 33% 0.732
No oral nutrition and TPN 8 29% 8 30%
Total oral nutrition 13 46% 10 37%
Nutrition after fistula
diagnosis (after DP)
No oral nutrition and total enteral nutrition using a
feeding tube
2 7% 3 11% 0.437
No oral nutrition and TPN 4 14% 7 26%
Total oral nutrition 22 79% 17 63%
Oral feeding after TPN (after
Whipple procedure)
This decision is not based on the status of the PF 14 50% 11 41% 0.424
When the PF is healed 2 7% 5 18%
When the PF output decreases 12 43% 11 41%
Oral feeding after TPN (after
DP)
This decision is not based on the status of the PF 15 54% 12 44% 0.706
When the PF is healed 1 4% 2 7%
When the PF output decreases 12 43% 13 48%
Somatostatin use (after
Whipple procedure)
Intraoperatively in all cases 4 14% 7 26% 0.491
Intraoperatively in cases of soft pancreas only 9 32% 11 41%
Never 4 14% 1 4%
Once a PF appears 7 25% 5 18%
Preoperatively in all cases 4 14% 3 11%
Somatostatin use (after DP) Intraoperatively in all cases 3 11% 7 26% 0.511
Intraoperatively in cases of soft pancreas only 6 21% 7 26%
Never 6 21% 5 18%
Once a PF appears 11 39% 6 22%
Preoperatively in all cases 2 7% 2 7%
Somatostatin duration (after
Whipple procedure)
7 days 12 43% 12 44% 0.679
<7 days 5 18% 5 18%
>7 days 3 11% 3 11%
Never use it 4 14% 1 4%
Until the PF heals 4 14% 6 22%
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whether the responding centre performed more or fewer than 50
Whipple procedures per year. Almost all centres reported the use
of postoperative drainage after Whipple surgery and DP regard-
less of the volume of cases (93% in both high- and low-volume
centres after Whipple surgery, and 89% and 93% in high- and
low-volume centres, respectively, after DP).After DP, high-volume
centres were more likely to remove drainage when the output of
amylase-rich fluid was low without any imaging (86% versus
59%), whereas after Whipple surgery, low-volume centres more
often used imaging prior to drain removal (11% versus 0%).
Similarly, low-volume centres were more likely to perform
imaging as soon as a POPF was diagnosed after Whipple surgery
and DP (37% versus 18% after Whipple surgery; 33% versus 18%
after DP), whereas high-volume centres used imaging modalities
only when an infected intra-abdominal collection was suspected
(82% versus 52% after Whipple surgery; 82% versus 56% after
DP). Finally, low-volume centres were more likely to discharge
patients only when the fistula had completely healed after
Whipple surgery, whereas high-volume centres tended to dis-
charge patients as soon as the fistula was draining well and oral
nutrition was well tolerated (89% versus 59% after Whipple
surgery; 93% versus 74% after DP).
European versus non-European centres
Only three items on the questionnaire resulted in significant dif-
ferences in responses between European and non-European
Table 2 Continued
Items Answer options Centres performing >50
Whipple procedures
per year (n = 28)
Centres performing <50
Whipple procedures
per year (n = 27)
P-value
n % n %
Somatostatin duration (after
DP)
7 days 9 32% 10 37% 0.676
<7 days 4 14% 5 18%
>7 days 3 11% 2 7%
Never use it 7 25% 3 11%
Until the PF heals 5 18% 7 26%
Antibiotics (after Whipple
procedure)
In cases of suspected infection 15 54% 14 52% 0.628
Never prescribe antibiotics 2 7% 1 4%
Systematically after surgery (prophylactic) 11 39% 11 41%
Systematically when PF appears 0 0% 1 4%
Antibiotics (after DP) In cases of suspected infection 15 54% 14 52% 0.999
Never prescribe antibiotics 2 7% 2 7%
Systematically after surgery (prophylactic) 10 36% 10 37%
Systematically when PF appears 1 4% 1 4%
Imaging strategy (after
Whipple procedure)
Before removing the prophylactic drains 0 0% 3 11% 0.033
In all cases, once a PF has been diagnosed 5 18% 10 37%
Only when an infected intra-abdominal collection is
suspected
23 82% 14 52%
Imaging strategy (after DP) Before removing the prophylactic drains 0 0% 3 11% 0.030
In all cases, once a PF has been diagnosed 5 18% 9 33%
Only when an infected intra-abdominal collection is
suspected
23 82% 15 56%
Criteria for re-laparotomy
(after Whipple procedure)
High PF output 0 0% 0 0% 0.491
Symptomatic collection which is undrainable by
interventional radiology
26 93% 27 100%
For both cases 2 7% 0 0%
Criteria for re-laparotomy
(after DP)
High PF output 0 0% 0 0% 1.000
Symptomatic collection which is undrainable by
interventional radiology
27 96% 27 100%
For both cases 1 4% 0 0%
Patient discharge (after
Whipple procedure)
Once the PF is draining well (drain in situ) and oral
nutrition is well tolerated
25 89% 17 63% 0.029
Once the PF has completely healed 3 11% 10 37%
Patient discharge (after DP) Once the PF is draining well (drain in situ) and oral
nutrition is well tolerated
26 93% 20 74% 0.063
Once the PF has completely healed 2 7% 7 26%
PF, pancreatic fistula; DP, distal pancreatectomy; TPN, total parenteral nutrition.
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centres: (i) pancreaticojejunostomy after DP was more commonly
performed in non-European centres (13% versus 0%; P = 0.019);
(ii) European centres were more likely to use prophylactic drain-
age with free drainage after both Whipple surgery and DP (70%
versus 20%; P = 0.004), and (iii) non-European centres used
somatostatin more often after both Whipple surgery and DP
when a fistula occurred [47% versus 13% after Whipple surgery
(P = 0.027); 60% versus 20% after DP (0.048)].
Discussion
Overall, this survey disclosed poor agreement on the management
of POPF after Whipple surgery and DP. At least six aspects of
current practice in the management of POPF are associated with
poor or no agreement among HPB centres worldwide: (i) the
removal of prophylactic drainage; (ii) type of nutrition; (iii) use of
somatostatin analogues; (iv) use of antibiotics; (v) imaging strat-
egy, and (vi) hospital discharge. Compared with centres perform-
ing fewer than 50Whipple procedures per year, high-volume units
appeared to be less conservative regarding hospital discharge and
imaging strategy. Overall, the management of POPF in European
versus non-European centres was similar.
The current management of POPF includes prophylactic drain-
age of pancreatic exocrine secretions, the provision of nutritional
support and the prevention of fistula-related complications.11,14,15
It is noteworthy that 70% of cases of POPF resolve spontane-
ously.14 The best therapeutic approach for the management of
POPF is still highly debated and most publications dealing with
this issue lack standardization.18–20 One of the most striking find-
ings of this survey is that >80% of items on the questionnaire
achieved poor or no agreement among centres after bothWhipple
surgery and DP, confirming a lack of consensus.
On the basis of a recent review of randomized controlled trials
(RCTs), the value of prophylactic drainage and strategies for its
management after pancreatic surgery remain unclear.21 Interest-
ingly, >90% of centres participating in the present survey used
prophylactic drainage in both Whipple surgery and DP. Although
the criteria for drain removal represented a point of poor agree-
ment among HPB centres, 73% of respondents indicated that
drainage was removed once the output of amylase-rich fluid was
low.Until now, there has been no consensus on the optimal timing
of the removal of prophylactic drainage after pancreatic surgery
when POPF is diagnosed, which is consistent with the results of
the present survey.
The second aspect of management to garner poor agreement
among centres concerned nutrition. Nutritional support is one of
the key elements of conservative therapy in patients with POPF as
most of these patients are in a catabolic state. In this setting, three
options are currently used, involving the provision of: (i) no oral
nutrition and total enteral nutrition using a feeding tube; (ii) no
oral nutrition and TPN, and (iii) total oral nutrition. Although
half of the respondents to the present survey reported using the
first two options, 40% used total oral nutrition when POPF was
diagnosed after Whipple surgery or DP. Only one RCT has com-
pared the efficacy and safety of enteral versus parenteral nutrition
in the conservative management of POPF.22 The authors con-
cluded that enteral nutrition is associated with significantly higher
closure rates and a shorter time to closure of POPF. By contrast,
according to a recent prospective study, enteral nutrition com-
bined with parenteral nutrition is associated with fewer compli-
cations compared with enteral nutrition alone after pancreatic
surgery.23 The decision to start oral feeding after TPN has not been
previously addressed in any study, which probably explains the
poor agreement on this issue among centres responding to this
survey. Thus, these data reflect a significant lack of consensus on
the nutritional management of POPF. Interestingly, responses to
this survey on the management of POPF were fairly similar in the
contexts of bothWhipple surgery and DP, except on issues related
to nutrition. Indeed, 71% of participating centres reported using
total oral nutrition after DP, whereas only 42% reported doing so
after Whipple surgery. In patients who have undergone DP, POPF
originates from the raw pancreatic surface rather than from an
anastomotic leak.
The use of synthetic somatostatin analogues (e.g. octreotide)
following pancreatic surgery is still under debate.24 The poor
agreement among participating centres on the use of somatostatin
mirrors the controversies related to its efficiency in preventing
POPF. A meta-analysis of 17 RCTs showed that somatostatin ana-
logues reduce perioperative complications, but do not reduce
perioperative mortality in pancreatic surgery.25 A more recent
meta-analysis concluded that the use of somatostatin analogues
does not result in a higher rate of POPF closure compared with
other treatments.26 With regard to the timing and duration of
somatostatin analogues, most studies reported that a first dose
given before surgery and for 7 days thereafter, as is the most
common practice in Europe, was associated with a positive
effect.27,28
Patients who experience any complications after pancreatic
surgery are associated with a three-fold increase in costs over
those without complications.6 It is of note that most of the com-
plications that occur after pancreatic surgery are related to POPF.
In the present study, although 76% of participating centres
reported the discharge of patients once the fistula was draining
well (drain in situ) and oral nutrition was well tolerated, 24% of
centres claimed to discharge patients only once the POPF had
completely healed. This may further contribute to a major
increase in cost, particularly in units with lower pancreatic surgery
activity. Indeed, low-volume centres tended to be more conserva-
tive in the management of POPF: 37% of those centres, compared
with 11% of high-volume centres, discharged patients only when
the POPF had completely healed. In addition, one third of low-
volume centres used abdominal imaging in all instances of diag-
nosed POPF. By contrast, high-volume units were more likely to
discharge patients even without the complete healing of the POPF
and without imaging, thereby promoting a cost reduction
strategy.
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Half of the respondents to the present survey reported
the use of antibiotics in patients with suspected infection and
the other half reported the use of antibiotics in a systematic
manner after surgery and with a prophylactic purpose. Infec-
tious complications occur in up to 17% of patients after pan-
creatic surgery,10 which compromises outcomes and markedly
increases costs.29 Pancreatic fistula-related infection accounts for
only 5–16% of all types of infection occurring after pancreatic
surgery.29–31 There are no data in the literature supporting the
systematic use of antibiotics after pancreatic surgery. However, in
patients with pancreatic cancer and obstructive jaundice, preop-
erative biliary drainage was associated with an increased rate of
postoperative infectious complications.32,33 In this setting, the
use of antibiotics should be evaluated in further prospective
trials.
Although the consensus statement of the International Study
Group on Pancreatic Fistula (ISGPF) provides definitions and a
system of grading POPF according to treatment options and
patient outcomes,8 it seems that each centre adopts its own policy
for the management of POPF regardless of the definition used. As
there is no consensus on the optimal management of POPF and
no standardized treatment, interpretations of the definitions of
POPF proposed by the ISGPF vary considerably according to the
treatment adopted to manage the issue.
Based on the current literature, very few firm statements can
be made. The criteria for drain removal, imaging strategy and
the timing of hospital discharge once POPF is diagnosed remain
unclear and should be evaluated in further prospective trials.8,21
The use of enteral nutrition should be preferred over TPN.22
There is no solid evidence that somatostatin analogues result in
a higher rate of closure of POPF than other treatments.26
There is no evidence to support the systematic use of antibio-
tics except in patients with cancer and preoperative biliary
drainage.32,33
One of the limitations of this survey is that 73% of participating
centres were based in Europe. However, whereas the use of a
prophylactic drain with free drainage was more frequent in
Europe, the use of somatostatin when POPF occurs was more
common in non-European centres. In addition, as this survey
included units with high levels of pancreatic surgery activity, it is
possible that its findings reflect current practice in a ‘super-select’
group of centres.
In conclusion, the findings of this survey offer opportunities for
the evaluation of current practice and the initiation of a further
process evaluation of the management of POPF. The high vari-
ability in definitions of and management strategies for POPF
mirrors the lack of consensus. For this purpose, an international
consensus based on the Danish/Zurich model and providing
statements and guidelines for the management of POPF that
could be accepted and applied internationally would be help-
ful.34,35 This would allow for the better comparison of future trials
andmight perhaps reduce the markedly high costs associated with
complications related to POPF.
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